As shown in Fig. 3B, CD34+ MM cells expressed CD112, CD137L, CD270, CD275, HLA-DR, and GAL9 at significantly higher rates than CD34− MM cells (P < 0.01). Here, TNFRSF14 is linked to Miyoshi myopathy.